PHGDH and osteoporosis: Our work has also important translational and therapeutic implications, as treatment of mice with a PHGDH small-molecule inhibitor completely prevented OVX-induced bone loss without affecting osteoblast parameters or inducing overall toxicity35,36, suggesting that the SSP represents a new therapeutic target to treat osteoporosis.